Literature DB >> 2239456

The "serotonin hypothesis" for depression in Parkinson's disease.

R Mayeux1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2239456

Source DB:  PubMed          Journal:  Adv Neurol        ISSN： 0091-3952


× No keyword cloud information.
  14 in total

1.  Mood and motor trajectories in Parkinson's disease: multivariate latent growth curve modeling.

Authors:  Laura B Zahodne; Michael Marsiske; Michael S Okun; Ramon L Rodriguez; Irene Malaty; Dawn Bowers
Journal:  Neuropsychology       Date:  2011-12-05       Impact factor: 3.295

2.  Preserved serotonin transporter binding in de novo Parkinson's disease: negative correlation with the dopamine transporter.

Authors:  Karl Strecker; Florian Wegner; Swen Hesse; Georg-Alexander Becker; Marianne Patt; Philipp M Meyer; Donald Lobsien; Johannes Schwarz; Osama Sabri
Journal:  J Neurol       Date:  2010-07-21       Impact factor: 4.849

Review 3.  Serotonergic mechanisms in Parkinson's disease: opposing results from preclinical and clinical data.

Authors:  B Scholtissen; F R J Verhey; H W M Steinbusch; A F G Leentjens
Journal:  J Neural Transm (Vienna)       Date:  2005-10-27       Impact factor: 3.575

4.  Proanthocyanidin-rich fraction from Croton celtidifolius Baill confers neuroprotection in the intranasal 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine rat model of Parkinson's disease.

Authors:  Eduardo L G Moreira; Daniel Rial; Aderbal S Aguiar; Cláudia P Figueiredo; Jarbas M Siqueira; Silvia DalBó; Heros Horst; Jade de Oliveira; Gianni Mancini; Tiago S dos Santos; Jardel G Villarinho; Francielle V Pinheiro; José Marino-Neto; Juliano Ferreira; Andreza F De Bem; Alexandra Latini; Moacir G Pizzolatti; Rosa M Ribeiro-do-Valle; Rui D S Prediger
Journal:  J Neural Transm (Vienna)       Date:  2010-10-08       Impact factor: 3.575

5.  Treatment with antidepressants and lithium is associated with increased risk of treatment with antiparkinson drugs: a pharmacoepidemiological study.

Authors:  M Brandt-Christensen; K Kvist; F M Nilsson; P K Andersen; L V Kessing
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-06       Impact factor: 10.154

6.  Influence of repeated levodopa administration on rabbit striatal serotonin metabolism, and comparison between striatal and CSF alterations.

Authors:  D A Loeffler; P A LeWitt; P L Juneau; D M Camp; A J DeMaggio; M K Havaich; P E Milbury; W R Matson
Journal:  Neurochem Res       Date:  1998-12       Impact factor: 3.996

Review 7.  Psychiatric aspects of Parkinson's disease--an update.

Authors:  Anette Schrag
Journal:  J Neurol       Date:  2004-07       Impact factor: 4.849

Review 8.  Neuropsychiatric symptoms in Parkinson's disease.

Authors:  Dag Aarsland; Laura Marsh; Anette Schrag
Journal:  Mov Disord       Date:  2009-11-15       Impact factor: 10.338

9.  Cortical serotonin and norepinephrine denervation in parkinsonism: preferential loss of the beaded serotonin innervation.

Authors:  Tultul Nayyar; Michael Bubser; Marcus C Ferguson; M Diana Neely; J Shawn Goodwin; Thomas J Montine; Ariel Y Deutch; Twum A Ansah
Journal:  Eur J Neurosci       Date:  2009-07       Impact factor: 3.386

Review 10.  [Depressive disorders with somatic illnesses].

Authors:  V Arolt; M Rothermundt
Journal:  Nervenarzt       Date:  2003-11       Impact factor: 1.214
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.